Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holly Morris

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Science Translational Medicine|June 27, 2014
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical modelsLihong Xu, Janine Stevens, Mary Beth Hilton, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Cancer Cell|April 12, 2017
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor VasculatureSteven Seaman, Zhongyu Zhu, Saurabh Saha, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Science Translational Medicine|June 27, 2014
COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical modelsLihong Xu, Janine Stevens, Mary Beth Hilton, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Cancer Cell|April 12, 2017
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor VasculatureSteven Seaman, Zhongyu Zhu, Saurabh Saha, et al.
Pageof 3